Media Coverage

The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.

  • NBC

    Harmful cholesterol levels cut in half with one-time gene editing drug in early trial

    Altering a single gene may help people lower dangerously high levels of cholesterol and other fats in the blood, according to new research presented Saturday at the annual meeting of the American Heart Association in New Orleans. The Phase 1 clinical trial of 15 people was intended to show whether the experimental gene-editing therapy was safe to use in humans.

    “What’s nice about this target of ANGPTL3 is that it not only lowers the LDL, the bad cholesterol, but it also has some effectiveness on people who have very high triglycerides,” said Dr. Elizabeth McNally, a human geneticist and cardiologist at the Northwestern Feinberg School of Medicine in Chicago.

  • CBS News

    Pennsylvania man says experimental drug has helped him recover from cycling accident

    An experimental drug could help improve movement for patients with spinal cord injuries, and it’s already making a big difference for one patient in Bensalem, Pennsylvania.

    Monica Perez, of the Shirley Ryan Ability Lab, is the lead investigator. She said she tested 20 patients with chronic incomplete cervical spinal cord injuries. Early results are positive, she said, and she’s hoping for more approvals from the FDA.

  • Associated Press

    A study questions melatonin use and heart health but don’t lose sleep over it

    Don’t lose sleep over headlines linking melatonin to heart failure. That’s the message after some scary-sounding reports about a preliminary study involving the sleep-related supplement. It raised questions about the safety of long term use of melatonin for insomnia.

    But only certain countries require a melatonin prescription. It’s over-the-counter in the U.S., meaning Americans in the study might have used the supplements without it being recorded, said Northwestern University cardiology chief Dr. Clyde Yancy, who wasn’t involved in the study. The study also did not show dosages.

  • New York Times

    Rise in Kidney Disease Tied to Other Chronic Conditions, Study Finds

    The number of adults with chronic kidney disease is growing, according to a study published Friday in The Lancet. The disease was the ninth leading cause of death worldwide in 2023, up from the 27th leading cause in 1990.

    “We should be doing a better job of identifying individuals at risk and intervening,” said Dr. Susan Quaggin, a former president of the American Society of Nephrology and chair of medicine at the Northwestern University Feinberg School of Medicine who was not involved in the study.

  • Fox News

    New pancreatic cancer treatment ‘wakes up’ immune cells, researchers say

    Scientists have created a new antibody treatment that helps the immune system recognize and attack pancreatic cancer.

    “Pancreatic cancer is notoriously good at hiding from the immune system, but we were struck that a single sugar, called sialic acid, can so powerfully fool immune cells,” senior author Mohamed Abdel-Mohsen, associate professor of medicine in the division of infectious diseases at Northwestern University Feinberg School of Medicine, told Fox News Digital.

  • Associated Press

    Disease of 1,000 faces shows how science is tackling immunity’s dark side

    Like with lupus, RA treatment is trial-and-error and scientists are exploring different underlying factors to explain why. In one study, an international team used tiny samples of patients’ joint tissue to identify six inflammatory subtypes of RA based on patterns of cells, how they clustered and their activity.

    It “changed how we think about the disease,” said Northwestern University rheumatology chief Harris Perlman, one of the coauthors. Now researchers are comparing cells in joint tissue before and after patients start a new drug to see if they could help guide treatment choices, he said.

  • New York Times

    Is Melatonin Bad for Your Heart? Here’s What to Know.

    This week, a series of headlines warned about the potential risks of taking the sleep supplement melatonin, saying new research had linked it to a 90 percent increase in heart failure. The research is from an unpublished study set to be presented at the American Heart Association’s scientific conference in New Orleans next week.

    It also lacked information about melatonin dosage and insomnia severity, said Dr. Phyllis Zee a sleep doctor and researcher at Northwestern Medicine who was not involved with the study. Both of these factors could affect heart risks.

  • USA Today

    Everyone’s buzzing about the blood test that detects 50 types of cancer. I tried it.

    I took the Galleri multi-cancer early detection (MCED) test about a year ago in 2024 as part of my longevity-focused stay at Canyon Ranch, a luxury wellness retreat in Tucson, Arizona. Galleri – which costs $949, and is not currently FDA-approved – is a blood test that studies DNA fragments shed into the bloodstream. Patients need a prescription before pulling up their sleeves.

    “The key plain takeaway: (This type of testing) may complement current screening by identifying lethal cancers that are otherwise undetected earlier and with limited downstream burden,” says Dr. Mohamed Abazeed, chair and professor of radiation oncology at Northwestern University, who was not involved with the study.

  • Fox Chicago

    Sleep expert explains when melatonin helps — and when it can do more harm

    After a new study linked melatonin to possible heart health risks, “ChicagoLIVE” speaks with sleep medicine specialist, Kelly Gill, MD, from Northwestern University about what the research really means. She explains when melatonin can be helpful, why timing and dosage matter more than strength, and how high doses may do more harm than good.

  • USA Today

    Dick Cheney had five heart attacks. Here’s how science helped him live until 84.

    As many reflect on the life of former Vice President Dick Cheney and his political legacy, others marvel at his longevity.

    Despite five heart attacks, multiple surgeries and a heart transplant, Cheney still lived a long life and died surrounded by his wife, daughters and other family members Nov. 3 at age 84.

    “Modern medicine has kept this man alive through all of these years through innovative advancements in the field of cardiology,” said Dr. Baljash Cheema, advanced heart failure and transplant cardiologist at Northwestern University Feinberg School of Medicine.